Mike Peters of The Alarm has appealed to people to become potential stem cell donors. Peters, who was forced to cancel a US ...

Patients with low-count chronic lymphocytic leukemia phenotype monoclonal B-cell lymphocytosis had a 1.86-fold greater risk of melanoma. A comparison of the second-generation Bruton tyrosine ...

Allogene Therapeutics has dropped plans to target one of its allogeneic CAR-Ts at leukemia in the face of competition from ...

Susan L. Slager, PhD, discussed the etiology and inherited genetic factors that are associated with the risk of chronic ...

Cyrus M. Khan, MD, discussed recent advancements in CLL treatment, particularly the shift to nonchemotherapy options and the ...

The frontman of Welsh rock band The Alarm is facing an uncertain future after his rare aggressive cancer returned. Mike ...

The Prestatyn-born rock star was given the all-clear earlier this year - but his rare and aggressive lymphoma returned last ...

The rock star, who was forced to cancel a US tour earlier this year after being diagnosed with fast-growing lymphoma, was ...

As an internationally-recognized expert in lymphoma, CLL, and cellular therapy, Dr. Patel’s research has been highlighted in ...

SEQ is the first and only assay to receive Medicare coverage for MRD assessment in MCLCoverage leverages new Medicare episode pricing ...

Allogene is ceasing enrollment in a Phase I trial of cema-cel for patients with relapsed or refractory chronic lymphocytic ...

Biological and Prognostic Subgroups of Plasmablastic Lymphoma Defined By EBV Status and MYC Rearrangement ... Degrader ...